Hepatobiliary & Liver Transplant SurgeryDr. Sandeep JhaLiver Cirrhosis

Sr. Consultant, Liver Transplant, HPB & GI Surgery, Metro Heart Institute with Multispeciality, Faridabad

Part 4 of 10 in Diagnosis and Management of Liver Cirrhosis

MELD and Child-Pugh Scores: Grading Cirrhosis and Timing a Transplant

June 16, 2024

Once cirrhosis is confirmed, two scoring systems are used to grade its severity and decide the timing of a liver transplant.

MELD and Child-Pugh scores

The MELD (Model for End-stage Liver Disease) score uses lab values including prothrombin time, bilirubin and albumin to calculate severity. The Child-Pugh (CTP) score combines lab values with clinical parameters. Both are used to recommend a patient for liver transplant. A CTP score of 13-15 carries close to a 40% three-month mortality; a MELD score above 30, up to around 35, carries up to a 52% chance of not surviving beyond three months. In decompensated cirrhosis generally, one-year survival is around 75% and five-year survival is under 50%.

Acute liver failure is a different, more urgent category

Acute liver failure and acute-on-chronic liver failure are distinct from cirrhosis: they are emergencies, often caused by drug-induced poisoning (including paracetamol overdose), rat poison, or hepatitis A or E, where the liver fails suddenly and the patient can die within 10-15 days without a liver transplant.

This article is based on a Jivo Masterclass session conducted by Dr. Sandeep Jha, Consultant Liver Transplant, Manipal Hospital, New Delhi. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

Looking for a liver transplant or hepatology consultation? Get in touch with the Jivo team

This guide is based on a live Jivo Masterclass: Dr. Sandeep Jha taught doctors across Africa on June 16, 2024.

FROM THE LIVE Q&A

JI

Jivo Doctor Partner (name unclear from transcript)

Do all patients with liver cirrhosis go on to develop features of decompensation?

SJ

Dr. Sandeep Jha

No, absolutely not. About 5% of cirrhosis patients decompensate every year. If cirrhosis is diagnosed early and risk factors are controlled (weight loss, diabetes control, hepatitis B/C control), there is a good chance the patient can live out their life with the same liver. However, there is no way to know in advance how long a given cirrhotic liver will last, which is why patients are placed under six-monthly surveillance instead.

See all 13 questions from this masterclass →

Book a Consultation with Dr. Sandeep Jha

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

How is the progression from fatty liver to cirrhosis diagnosed and managed?

The first step is to determine whether cirrhosis has actually developed, using a fibroscan or, less often now, a liver biopsy. If the disease is only at the steatohepatitis stage (fatty liver inflammation with no fibrosis yet), controlling risk factors can make it fully resolve. If cirrhosis has already developed, the patient is kept under regular monitoring, since there is no way to predict when a cirrhotic liver will start to fail.

What are the exam findings of cirrhosis, and when do they appear?

On examination, jaundice, ascites, leg oedema, spider angiomas, palmar erythema and gynaecomastia are the telltale signs of cirrhosis. Unfortunately, these are only seen in advanced cirrhosis. Since the goal is to catch cirrhosis before complications develop, an ultrasound or fibroscan done proactively is the better approach for early diagnosis.

What are the effective drugs for hepatitis B and C?

For hepatitis B, tenofovir and entecavir are very effective drugs with low resistance levels that can practically control the virus. For hepatitis C, directly-acting agents such as sofosbuvir and velpatasvir are very effective and can practically eliminate the virus from the body.

What is the donor's recovery timeline after living donor liver transplant?

The donor is admitted for about seven days. By the third or fourth day, the donor is walking around, eating, and relatively pain-free, and is discharged by day six or seven. A follow-up OPD visit happens on day 10; if doing fine, the donor can return to their home country and resume office and light household work, with the only restriction being on lifting heavy weights.

What is the recipient's recovery timeline after living donor liver transplant?

This depends on how sick the recipient was before surgery: a weaker, sicker patient takes longer to recover. The recipient typically stays in hospital for around 18 days, with discharges starting around day 12-13 and about 95% discharged by day 18. Complete recovery, meaning a return to normal muscle mass and full function, takes about two to three months. After 2-3 weeks of local follow-up near the hospital in India, the patient can return to their home country and continue follow-up from there.

What are MELD and Child-Pugh scores used for?

Both grade the severity of cirrhosis using lab values (and, for Child-Pugh, clinical parameters) and are used to recommend the timing of a liver transplant.

What is acute liver failure?

A distinct, more urgent condition from cirrhosis where the liver fails suddenly, often from drug poisoning or hepatitis A/E, with death possible within 10-15 days without transplant.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion